Navigation Links
Eisai Inc. and the Alzheimer's Association Honor Community Pharmacist for Outstanding Service to Individuals with Alzheimer's Disease
Date:10/29/2009

ard recipient for her invaluable contributions to enhance the quality of care for people affected by Alzheimer's disease."

"As a member of the C.A.R.E. Pharmacy Award selection committee, I saw the impressive contributions of nominated pharmacists who work as a part of a cohesive team of care providers for people with Alzheimer's disease," said Elizabeth Gould, MSW, LCSW, director of quality care programs for the Alzheimer's Association. "We applaud this year's winner on her extraordinary efforts in building a relationship with those living with Alzheimer's and their caregivers, helping to educate them about Alzheimer's disease and enhancing the support they receive."

A $1,500 donation will be made to the Greater Richmond Alzheimer's Association Chapter, which serves the area where the award recipient resides, and also to the Massachusetts/New Hampshire and Greater Illinois Alzheimer's Association Chapters in recognition of having the most award nominations submitted from within their service areas.

About Eisai Inc.

Eisai Inc. is a wholly-owned subsidiary of Eisai Corporation of North America. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), the company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business with fiscal year 2008 (year ended March 31, 2009) sales of approximately $3.7 billion. Eisai Inc.'s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Headquartered in Woodcliff Lake, New Jersey, Eisai Inc. has several R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as manufacturin
'/>"/>

SOURCE Eisai Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
2. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
3. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
4. Confusion over Influenzinum Clarified by the American Association of Homeopathic Pharmacists (AAHP)
5. American Association for Homecare Proposes Strong Anti-Fraud Measures in Medicare, Applauds HHS Testimony Today That Pledges to "Stop Fraud Before it Starts"
6. American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento
7. Ikaria Receives Award for Excellence by New Jersey Business & Industry Association
8. American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment
9. American Hospital Association (AHA) Names OnBase RACTrac Compatible
10. American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver
11. American Lung Association of the Mid-Atlantic Kicks Off 2009-2010 Faces of Influenza Campaign in Philadelphia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Persistence Market Research ... Market Study on Ophthalmic Devices: Asia ... devices market was valued at USD 29,171.5 million in 2014 ... 6.5% from 2014 to 2020, to reach an estimated ... Browse the full Global Market Study on Ophthalmic Devices:  ...
(Date:9/22/2014)... Sept. 22, 2014  Neuralstem, Inc. (NYSE MKT: CUR) announced ... at Emory University, presented long-term follow up data on ... cells in the treatment of amyotrophic lateral sclerosis (ALS ... occurred at the Annual Symposium on ALS of the ... on Friday, and was not open to the public, ...
(Date:9/22/2014)... 22, 2014  For many people experiencing issues ... facing the prospect of large, painful incisions and ... activities are also impacted, such as working, driving ... the problem, some patients even delay necessary treatment, ... lead to permanent damage for some conditions. ...
Breaking Medicine Technology:Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2
... SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ - NeurogesX, ... on developing and,commercializing novel pain management therapies, announced ... lead product candidate, NGX-4010, in the,journal Neurology. The ... Treatment of Painful HIV,Neuropathy," will appear in the ...
... open-label study presented ... at ... AMLN ) today announced data showing that the use of ... in more patients achieving diabetes treatment goals of,improved glucose control without ...
Cached Medicine Technology:NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 2NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology 3Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 2Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 3Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 4Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin 5
(Date:9/22/2014)... 22, 2014 On Tuesday, September 16th, 2014, ... first evening show, “KC After Dark.” Hosted by top ... Dark” will air every Tuesday at 8:00 p.m. EST. WRNW1 ... the 50th caller, and because of the amazing turnout for ... in mark with 500 callers. , During this comical, ...
(Date:9/22/2014)... people both exercise more and drink more , Study ... activity , Findings differ from past research on physical ... Medicine study finds that on days when people exercise ... more alcohol, too. , This is the only study ... for self-reporting physical activity and alcohol use. , "Monday ...
(Date:9/22/2014)... 22, 2014 Transvaginal mesh lawsuits ... continue to move forward in the federal multidistrict ... District of West Virginia, Bernstein Liebhard LLP reports. ... Order was issued by the Court on September ... to the upcoming trial for consolidated lawsuits involving ...
(Date:9/22/2014)... Boston, MA Up to 40 percent of patients ... may fail to remove all the cancerous tissue in ... Hospital (BWH) have successfully tested a tool they developed ... from normal tissue, thereby decreasing the chances for repeat ... online the week of September 22, 2014 in the ...
(Date:9/22/2014)... An inventor and anesthesiologist applied what she learned ... "My lower arm always became numb when I slept ... this problem," she said. "It’s better to be able ... 'fall asleep.'" , The Sleeping Pillow enables a user ... It avoids pain and restlessness by reducing pressure on ...
Breaking Medicine News(10 mins):Health News:The Women’s Radio Network, WRNW1’s First Evening Show a Huge Success 2Health News:We drink more alcohol on gym days 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 4Health News:The fine line between breast cancer and normal tissues 2
... SAGE and the European Society of Cardiology (ESC) have ... Acute Cardiovascular Care. The first issue will be published ... over 70,000 cardiology professionals across Europe and the Mediterranean, ... publishing seven of the world,s leading cardiology journals. ...
... 17 (HealthDay News) -- From buying a Christmas tree to stringing ... and safety issues parents and guardians should consider during the holidays, ... offers the following tips to help keep children and the whole ... sure, if you select an artificial tree, that it is flame-resistant. ...
... The busy holiday season may disrupt many people,s daily routines, ... to remember to look after your teeth, an expert advises. ... treats and drink alcoholic beverages more than usual," Dr. George ... an academy news release. "Additionally, with their busy schedules ...
... It,s not likely that a policy of presumed consent would ... according to a new study. Under such a ... organs after death unless they explicitly forbid it while they,re ... say it would help ease the organ shortage in the ...
... Will a drug used to treat childhood acute lymphoblastic leukemia ... UB associate professor of pharmaceutical sciences, Javier G. ... research and clinical practice, has focused recent efforts on trying ... study in the Journal of Clinical Oncology looked for the ...
... News) -- ,Draft recommendations meant to increase the number ... released Friday by the U.S. Food and Drug Administration. ... factors, and types of illness may cause women to ... men, according to the FDA. But, women are ...
Cached Medicine News:Health News:Sage and European Society of Cardiology extend publishing partnership 2Health News:Pediatricians Offer Tips to Avoid Holiday Hazards 2Health News:Pediatricians Offer Tips to Avoid Holiday Hazards 3Health News:Dentist Gives Advice to Keep Holiday Smiles Bright 2Health News:Presumed Consent Wouldn't Boost U.S. Organ Donation: Study 2Health News:Childhood cancer drugs cure now, may cause problems later, UB research shows 2Health News:FDA Seeks to Get More Women Into Trials of Medical Devices 2
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
... spill-proof design and effective output, even when ... medical nebulizers are free-standing for easy preparation., ... available., ,All Portex® medication nebulizer products ... feature consistently fine misting and the efficient ...
... a spill-proof design and effective output, even ... All medical nebulizers are free-standing for easy ... are available., ,All Portex® medication nebulizer ... nebulizers feature consistently fine misting and the ...
... with metered dose inhalers., ,ACE ensures ... MDI canisters. Its versatile design allows it ... in conjunction with an endotracheal airway or ... ACE may also be used in conjunction ...
Medicine Products: